ZA968227B - Hormone replacement therapy method and hormone dispenser - Google Patents

Hormone replacement therapy method and hormone dispenser

Info

Publication number
ZA968227B
ZA968227B ZA968227A ZA968227A ZA968227B ZA 968227 B ZA968227 B ZA 968227B ZA 968227 A ZA968227 A ZA 968227A ZA 968227 A ZA968227 A ZA 968227A ZA 968227 B ZA968227 B ZA 968227B
Authority
ZA
South Africa
Prior art keywords
dispenser
hormone
estrogen
progestogen
replacement therapy
Prior art date
Application number
ZA968227A
Other languages
English (en)
Inventor
Joerg Elliesen
Jutta Riedl
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24134029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA968227(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA968227B publication Critical patent/ZA968227B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/0005—Containers or packages provided with a piston or with a movable bottom or partition having approximately the same section as the container
    • B65D83/0011—Containers or packages provided with a piston or with a movable bottom or partition having approximately the same section as the container moved by a screw-shaft
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D35/00—Pliable tubular containers adapted to be permanently or temporarily deformed to expel contents, e.g. collapsible tubes for toothpaste or other plastic or semi-liquid material; Holders therefor
    • B65D35/22—Pliable tubular containers adapted to be permanently or temporarily deformed to expel contents, e.g. collapsible tubes for toothpaste or other plastic or semi-liquid material; Holders therefor with two or more compartments
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
    • B65D81/325—Containers having parallel or coaxial compartments, provided with a piston or a movable bottom for discharging contents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00—Containers or packages with special means for dispensing contents
    • B65D83/0005—Containers or packages provided with a piston or with a movable bottom or partition having approximately the same section as the container

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)
  • Steroid Compounds (AREA)
  • Catching Or Destruction (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
ZA968227A 1995-09-28 1996-09-30 Hormone replacement therapy method and hormone dispenser ZA968227B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53540295A 1995-09-28 1995-09-28

Publications (1)

Publication Number Publication Date
ZA968227B true ZA968227B (en) 1997-07-21

Family

ID=24134029

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA968227A ZA968227B (en) 1995-09-28 1996-09-30 Hormone replacement therapy method and hormone dispenser

Country Status (24)

Country Link
US (2) US5922349A (tr)
EP (1) EP0854705B1 (tr)
JP (1) JPH11512703A (tr)
KR (1) KR20000004898A (tr)
CN (1) CN1158206C (tr)
AT (1) ATE255406T1 (tr)
AU (1) AU714084B2 (tr)
BR (1) BR9610915A (tr)
CA (1) CA2232621A1 (tr)
CZ (1) CZ95598A3 (tr)
DE (1) DE69630968T2 (tr)
DK (1) DK0854705T3 (tr)
ES (1) ES2211983T3 (tr)
HK (1) HK1016887A1 (tr)
HU (1) HUP9802608A3 (tr)
IL (1) IL123691A (tr)
MX (1) MX9802370A (tr)
NO (1) NO320491B1 (tr)
PL (1) PL185848B1 (tr)
PT (1) PT854705E (tr)
TR (1) TR199800560T1 (tr)
TW (1) TW329389B (tr)
WO (1) WO1997011680A2 (tr)
ZA (1) ZA968227B (tr)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6551611B2 (en) * 1995-09-28 2003-04-22 Schering Aktiengesellschaft Hormone replacement therapy method
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
JP2001509477A (ja) * 1997-07-08 2001-07-24 デーエスエム・ナムローゼ・フェンノートシャップ ベンゾイルペルオキシドと第二活性成分との組合せの局所適用
CA2267743C (en) 1999-03-30 2011-07-26 Robert F. Casper Low dose estrogen interrupted hormone replacement therapy
AU2005201151B2 (en) * 1999-03-30 2008-01-10 Jencap Research Ltd Low dose estrogen interrupted hormone replacement therapy
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
NZ517845A (en) * 1999-08-31 2004-12-24 Schering Ag Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
EP2305267A3 (en) * 1999-08-31 2011-08-17 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
US20040191276A1 (en) * 1999-11-30 2004-09-30 Cutispharma, Inc. Compositions and kits for compounding pharmaceuticals
CN101934078A (zh) * 2000-01-18 2011-01-05 拜耳先灵医药股份有限公司 包含屈螺酮和雌激素的药物组合物及其应用
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
AU2991301A (en) * 2000-01-28 2001-08-07 Endorecherche Inc. Selective estrogen receptor modulators in combination with estrogens
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US7198801B2 (en) * 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
ATE355854T1 (de) * 2000-08-03 2007-03-15 Antares Pharma Ipl Ag Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
US20040198706A1 (en) * 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US20040172169A1 (en) * 2001-03-02 2004-09-02 Curtis Wright Method and apparatus for compouding individualized dosege forms
AU2002240949A1 (en) * 2001-03-21 2002-10-03 Schering Aktiengesellschaft Pharmaceutical combined preparations containing aromatase inhibitors and substances having an estrogen effect in addition to the use thereof for producing a medicament for estrogen-replacement-therapy
US7455656B2 (en) * 2001-07-26 2008-11-25 Langeler Gerard E Pill delivery system
AU2003213956A1 (en) * 2002-04-03 2003-10-13 Jencap Research Ltd. Improved hormone replacement therapy
UA87437C2 (ru) * 2002-04-26 2009-07-27 Бристол-Майерс Сквибб Компани Айседжен Инк Лечение гипертензии у женщин, которые поддаются гормонзаместительной терапии
US20040062794A1 (en) * 2002-09-30 2004-04-01 Lee Shulman 17Beta- estradiol/levonorgestrel transdermal patch for hormone replacement therapy
US7786101B2 (en) * 2002-11-05 2010-08-31 Bayer Schering Pharma Ag Cardiovascular protection using anti-aldosteronic progestins
US6669390B1 (en) 2002-11-22 2003-12-30 John J. Porter Breath freshener with mouthwash atomizer
US7354598B2 (en) * 2002-12-20 2008-04-08 Kimberly-Clark Worldwide, Inc. Packaging two different substrates
US7858607B2 (en) * 2003-03-14 2010-12-28 Mamchur Stephen A System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
US7785584B2 (en) * 2003-08-13 2010-08-31 Healthpoint, Ltd. Ointment wound spray
EP1670433B1 (en) 2003-10-10 2011-11-23 Antares Pharma IPL AG Transdermal pharmaceutical formulation for minimizing skin residues
US7293738B2 (en) * 2003-11-26 2007-11-13 Kimberly-Clark Worldwide, Inc. Freestanding dispenser for dispensing two different substrates
US20050222106A1 (en) * 2004-04-01 2005-10-06 Stefan Bracht Drospirenone-containing preparations for transdermal use
US7425340B2 (en) * 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US20060040904A1 (en) * 2004-08-17 2006-02-23 Ahmed Salah U Vaginal cream compositions, kits thereof and methods of using thereof
WO2007124250A2 (en) * 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
US7537139B2 (en) * 2005-05-27 2009-05-26 Henkel Corporation Dual chamber piston pressure pack dispenser system
WO2006125642A1 (en) * 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
JP2009501722A (ja) * 2005-07-15 2009-01-22 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ドロスピレノン含有経皮用薬剤供給装置及びその供給方法
EP2289486A1 (en) * 2005-12-27 2011-03-02 Teva Women's Health, Inc. Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US7476291B2 (en) * 2006-09-28 2009-01-13 Lam Research Corporation High chamber temperature process and chamber design for photo-resist stripping and post-metal etch passivation
WO2008067991A2 (en) * 2006-12-08 2008-06-12 Antares Pharma Ipl Ag Skin-friendly drug complexes for transdermal administration
US9795617B2 (en) 2009-06-18 2017-10-24 Baucom Institute for Longevity and Life Enhancement, Inc. Hormone delivery system and method
US8658628B2 (en) * 2009-06-18 2014-02-25 Karan Y. Baucom Hormone delivery system and method
WO2012151295A2 (en) 2011-05-02 2012-11-08 Mouse Trap Design, Llc Mixing and dispensing device
CA2745320A1 (en) * 2011-07-06 2013-01-06 Duoject Medical Systems Inc. Reconstitution device
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
WO2015070097A1 (en) 2013-11-07 2015-05-14 Mouse Trap Design, Llc Mixing and dispensing device
JP2017516768A (ja) 2014-05-22 2017-06-22 セラピューティックスエムディー インコーポレーテッドＴｈｅｒａｐｅｕｔｉｃｓｍｄ， Ｉｎｃ． 天然の併用ホルモン補充療法剤及び療法
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
EP3156349B1 (en) * 2015-10-16 2018-07-04 Fontem Holdings 1 B.V. Mixing bottle
US9903747B2 (en) * 2015-11-12 2018-02-27 Nodari Rizun Device and method for dispersing paste-like or sticky nutritional substance in a fluid
US10184818B2 (en) 2015-11-12 2019-01-22 Nodari Rizun Device and method for dispensing paste-like or sticky nutritional substance
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
EP3435977A4 (en) 2016-04-01 2019-10-16 Therapeuticsmd, Inc. PHARMACEUTICAL COMPOSITION OF STEROID HORMONE
CN108310608B (zh) * 2018-02-02 2020-07-31 韩明辉 一种医疗康复护理用涂药器
US10285998B1 (en) 2018-04-04 2019-05-14 The Menopause Method, Inc. Composition and method to aid in hormone replacement therapy
US11382400B2 (en) 2018-08-10 2022-07-12 Go Products Co. Material applicator
WO2020030975A2 (en) * 2018-08-10 2020-02-13 Azura Ophthalmics Ltd. Dispenser for precise extraction of a semi-solid product
CN111038860A (zh) * 2018-10-12 2020-04-21 元盛生医电子股份有限公司 容器结构
JP7315727B2 (ja) * 2019-07-09 2023-07-26 ザ プロクター アンド ギャンブル カンパニー 多組成物製品ディスペンサ
EP4087655A4 (en) 2020-01-10 2024-02-21 Azura Ophthalmics Ltd INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1586771A (en) * 1976-10-22 1981-03-25 Plessey Co Ltd Taximeter
DE2927584A1 (de) * 1979-07-07 1981-01-22 Henkel Kgaa Vorrichtung zum dosieren von zweikomponenten-produkten
FR2525183A2 (fr) * 1982-04-19 1983-10-21 Fabre Sa Pierre Dispositif de distribution en proportion reglable de deux substances pateuses
US4871092A (en) * 1982-07-10 1989-10-03 Ing. Erich Pfeiffer Gmbh & Co. Kg Atomizing or metering pump
US4687663B1 (en) * 1983-03-01 1997-10-07 Chesebrough Ponds Usa Co Dental preparation article and method for storage and delivery thereof
US4705783A (en) * 1985-06-25 1987-11-10 Sri International 9α, 11β-substituted and 11β-substituted estranes
DE3614515A1 (de) * 1986-04-29 1987-11-05 Pfeiffer Erich Gmbh & Co Kg Austragvorrichtung fuer medien
DK174724B1 (da) * 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
US4906169A (en) * 1986-12-29 1990-03-06 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US5422119A (en) * 1987-09-24 1995-06-06 Jencap Research Ltd. Transdermal hormone replacement therapy
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US4838457A (en) * 1988-05-09 1989-06-13 Swahl James C Lotion blending and dispensing unit
US5020694A (en) * 1989-03-16 1991-06-04 Chesebrough-Pond's, Inc. Multi-cavity dispensing container
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
FR2652567B1 (fr) * 1989-10-04 1992-01-10 Oreal Dispositif de distribution comportant au moins un flacon a embout cassable.
US5116865A (en) * 1990-09-05 1992-05-26 Peters Richard H 15,16-seco-19-nor progestins
US5286258A (en) * 1991-03-08 1994-02-15 Habley Medical Technology Corporation Multipharmaceutical delivery system
US5240146A (en) * 1990-12-14 1993-08-31 Smedley William H Variable proportion dispenser
US5518734A (en) * 1991-09-25 1996-05-21 Beta Pharmaceuticals Co. Transdermal delivery system for estradiol and process for manufacturing said device
US5339990A (en) * 1992-11-10 1994-08-23 Wilder Robert E Adjustable pump dispenser
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy

Also Published As

Publication number Publication date
BR9610915A (pt) 1999-03-30
NO320491B1 (no) 2005-12-12
US5922349A (en) 1999-07-13
CN1158206C (zh) 2004-07-21
PL325978A1 (en) 1998-08-17
TW329389B (en) 1998-04-11
HUP9802608A3 (en) 1999-07-28
CA2232621A1 (en) 1997-04-03
EP0854705B1 (en) 2003-12-03
IL123691A (en) 2001-10-31
HK1016887A1 (en) 1999-11-12
IL123691A0 (en) 1998-10-30
WO1997011680A3 (en) 1997-04-24
PL185848B1 (pl) 2003-08-29
CZ95598A3 (cs) 1999-06-16
ES2211983T3 (es) 2004-07-16
EP0854705A2 (en) 1998-07-29
DE69630968D1 (en) 2004-01-15
NO981412L (no) 1998-05-12
NO981412D0 (no) 1998-03-27
AU714084B2 (en) 1999-12-16
JPH11512703A (ja) 1999-11-02
AU7282796A (en) 1997-04-17
TR199800560T1 (tr) 1998-06-22
WO1997011680A2 (en) 1997-04-03
MX9802370A (es) 1998-08-30
ATE255406T1 (de) 2003-12-15
CN1198093A (zh) 1998-11-04
HUP9802608A2 (hu) 1999-02-01
KR20000004898A (ko) 2000-01-25
DE69630968T2 (de) 2004-10-21
US5897539A (en) 1999-04-27
DK0854705T3 (da) 2004-04-13
PT854705E (pt) 2004-04-30

Similar Documents

Publication Publication Date Title
ZA968227B (en) Hormone replacement therapy method and hormone dispenser
EP0581057B1 (de) Einzeldosierte halbfeste topische Arzneiformen zur Transdermaltherapie
AU1191092A (en) Ovulation-preventing agent for hormonal contraception
UA32636C2 (uk) Засіб для зниження вмісту холестерину в сироватці крові людини
CA2293488A1 (en) Dispenser with doses counter
CA2267743A1 (en) Low dose estrogen interrupted hormone replacement therapy
CA2105165A1 (en) Dosage form for a delayed drug-delivery
PL330916A1 (en) Progestagen-antiprogestagen dosing schemes
HU9502087D0 (en) Novel colon- or ileum-specific steroid derivatives
MX9702381A (es) Medicamentos hormonales nuevos y su uso para corregir deficiencias de estrogeno.
AU2691197A (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
AU6753387A (en) Unit dosage delivery device
TH48404A (th) วิธีการบำบัดโดยการทดแทนฮอร์โมนและแจกจ่ายฮอร์โมน
TH14163EX (th) " ยาคุมกำเนิดที่มีสารต้านโพรเจสโทเจน "
TH14163A (th) " ยาคุมกำเนิดที่มีสารต้านโพรเจสโทเจน "
CA1274807C (en) DEBITOR-DOSING DEVICE
CA2261655A1 (en) Transdermal therapeutical approach involving a combination of active substances containing oestriol
HUP9903097A2 (hu) Progesztogén-antiprogesztogén tartalmú gyógyszerkészítmény
GB9215984D0 (en) Dispenser for comminuting and delivering liquid products such as therapeutic drugs,healthcare and other formulated preparations
GEP19991588B (en) Medicinal Tablet
MX9701067A (es) Unidad de venta para la aplicacion parenteral, dispositivo para la realizacion de la aplicacion parenteral asi como unidad de relleno para la unidad de venta anterior.
AU3662300A (en) Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding